logo
Select company
Select metric
Ticker Information

Ticker

NXTC

Company Name

NEXTCURE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEXTCURE INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NXTC - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -57.7M0%$ 0
3/31/2025$ -46.24M0%$ 0
12/31/2024$ -52.23M0%$ 0
9/30/2024$ -54.93M0%$ 0
6/30/2024$ -57.44M0%$ 0
3/31/2024$ -59.65M0%$ 0
12/31/2023$ -58.47M0%$ 0
9/30/2023$ -60.91M0%$ 0
6/30/2023$ -65.59M0%$ 0
3/31/2023$ -66.73M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NEXTCURE INC is calculated as follows: EBITDA [ $ -28.89M ] / Revenues [ $ 24.38M ]
(=) EBITDA % [ -118.49% ]

NXTC - EBITDA Margin, Last 5 years

-148.32%

Minimum

Dec 31, 2020

-118.49%

Maximum

Sep 30, 2020

-133.4%

Average

-133.4%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%